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Abstract 
Background: Amblyopia is considered as one of the most prevalent vision problems in pediatrics age (1-5%). 
Recently, new methods in amblyopia treatment were reported in Amblyopia Treatment Study (ATS’).The 
objective of this study was to recognize amblyopia treatment knowledge of Iranian ophthalmologists and 
optometrists which are responsible for amblyopia treatment in our and other countries. 
Materials and Methods: This cross sectional study was performed during the Iranian Society of 
Ophthalmology annual meeting in Tehran in 2012 through questionnaire containing demographic information 
and 20 closed-answer questions based on ATS results. The questions were classified into seven categories and 
the sum of correct scores was 100. Optometrists and pediatric ophthalmologists were considered as the group 1 
(153 participants), other practitioners (general ophthalmologists and other subspecialists) were regarded as the 
group 2 (256 participants). Criteria for inadequate, fair and good knowledge were considered by scores of < 50, 
50 to 70, and >70 respectively. 
Results: Overall, 409 out of a total of 600 questionnaires were completed (response rate: 68.1%).  Mean 
scores of the group 1 were significantly higher than the group 2 in all 7 categories of questions and in 5 of 
them the differences were statistically significant. The worst and best scores were related to prescription of 
atropine (12%) and visual acuity improvement with glasses alone (93%), respectively. Scores for other 
questions were about 50%. There was no relationship between practice status and the number of referral 
amblyopic cases per week with the level of knowledge. In all categories except prescription of Atropine and 
recurrence, mean scores of females were more than the male participants. 
Conclusion: knowledge about amblyopia therapy seems to be overall inadequate and should be improved by 
more education. We suggest paying more attention to new modified methods of amblyopia treatment and 
increased discussion of such method in annual and CME meetings. 
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Amblyopia or “lazy eye” has been considered as one 
of the most prevalent vision problems in pediatrics 
and its incidence has been reported to be 1-5% in 
various populations, equivalent to 70-350 million 
people globally
1-8
. Anisometropia, strabismus, and 
visual deprivation are recognized as the main reasons 
leading to reduced vision
4,5
. The main goal in 
amblyopia treatment is to improve non dominant eye 
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vision through sending a clear image simultaneously 
for both eyes. This is available through one or a 
combination of methods including: refractive error 
corrections, different types of occlusion using patch, 
filters or penalization, and surgical alignment and 
continuous follow up appointments during and after 
treatment at least up to 10 years old
5,6
. The prognosis 
of amblyopia treatment depends strongly on the 
patient’s age, etiology, severity and duration of 




Nowadays, there are still many children who remain 
undiagnosed due to low sensitivity of amblyopia 
screening tests; however, the problem could be 
completely solved if the amblyopic child is 
diagnosed before the age of six
5
. Treatment of older 
children usually are more difficult and all affect 
patients must be treated regardless of their age
7
. In 
recent years, many worthwhile studies have been 
carried out with the standard and correct 
methodologies in relation to the result of glasses 
prescriptions, comparing efficacy of occlusion with 
penalization method, and evaluating treatment 
benefits in older ages. Such studies titled 
“Amblyopia Treatment Study” (ATS) have 
been performed on 1 to 17 items and the results of 
the first ten have been published, and others are 
under investigation
9-20
.  Awareness of ATS’ results 
and following them should be the first priority of all 
optometrists and pediatric ophthalmologists, as they 
are directly responsible for amblyopia treatment. 
Other fellowships also need to know the results of 
these studies since the possibility of referring 
amblyopic children to them exists, especially in the 
rural areas.   
Although ATS’ recommendations have been 
published many practitioners do not follow them and 
treat their amblyopic patients with older methods.  
The aim of this study was to recognize amblyopia 
treatment knowledge of Iranian practitioners by 
responding to a questionnaire which was designed 
according to ATS’ results. If their amblyopia 
treatment knowledge scores were not acceptable, 
they should become more familiar with new methods 
of treatments through planning CME courses 
focusing on updates of amblyopia management. 
Methods 
This cross sectional study was performed during the 
22nd Iranian annual congress of ophthalmology held 
by Tehran University of Medical Sciences in Tehran 
capital city of Iran on November 2012 and analysis 
this data in April 2013. The Ethics Committee of the 
Ophthalmic Research Center approved the study. Due 
to lack of insurance referral system in amblyopia 
treatment, amblyopia patients have been treated by 
ophthalmologists and optometrist according to their 
preference. 
Ophthalmologists and optometrists from all provinces 
of Iran participated. They were asked to answer a 
nameless questionnaire containing their demographic 
information and 20 closed answer questions based on 
ATS' recommendations. Participants were selected 
sequentially. 600 questionnaires were distributed 
among participants at baseline, and at the end of the 
study 409 questionnaires were completed. 
Questionnaire: The questionnaire included questions 
about the age, gender, province and period of practice, 
the last educational degree, practice status, amount of 
patching in different intensities of amblyopia, first 
choice of amblyopia treatment, patch or atropine in 
(moderate, severe, bilateral refractive amblyopia), 
methods of treatment in 7-12 and 13-17 year-old 
children, the impact of supplementary methods 
including one hour daily near/far work, cut-off trends 
and recurrent percentage rate. The choice “I do not 
know” was considered when any question had no 
answer. In order to improve the response rate, some 
small gifts were given to all participants. The lists of 
participants were also compared to the former 
prepared list of total ophthalmologists and 
optometrists to prevent repeated replies. Validity and 
reliability were measured with Cronbach's α 
coefficient. 
Sum of the correct scores of 20 questions was equal to 
100. Criteria for inadequate, fair and good knowledge 
were considered by scores of <50, 50 to 70 and >70, 
respectively. 
Participants were classified into 2 groups according to 
their education in relation to amblyopia treatment. 
Optometrists and pediatric ophthalmologists (153 
participants) whose education is directly in line with 
amblyopia treatment were considered as group 1, and 
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general ophthalmologists and other subspecialists 
(256 participants) whose education is not directly in 
line with amblyopia treatment were considered as 
group 2.  
Statistical analysis: In order to describe the data, the 
frequency, percentage, range, mean, standard 
deviation and median were calculated. 95% 
confidence interval was also calculated to evaluate 
the accuracy of estimations. The statistical 
examinations of Kruskal Wallis and Mann-Whitney 
were applied as well. All statistical analyses were 
performed using SPSS version 20.0 (IBM/SPSS Inc., 
Chicago, IL, USA). 
Results 
Overall, 409 practitioners participated in the current 
study (response rate was 68.1%) including 24 
pediatric ophthalmologists and 129 optometrists, and 
256 were general ophthalmologists and other 
subspecialists. Twenty questions were classified into 
seven groups, including:  
1. The duration and type of patching in various 
intensities of amblyopia. 
2. How to prescribe Atropine and possibility of its 
replacement by patching 
3. Addition of one hour daily far or near work 
4. How treat older children (7-17 year-old)  
5. Vision improvement by prescription of glasses only 
6. First choice of treatment in refractive amblyopia 
7. Amblyopia recurrence rate 
Table 1: Epidemiologic Characteristics of Participants. 
    N (%) 
Sex Total 397 (100.0) 
 
Male 255 (64.2) 
 
Female 142 (35.8) 
Age Categories (years) Total 360 (100.0) 
 
<=40 187 (51.9) 
 
>40 173 (48.1) 
Province of Practice Total 397 (100.0) 
 
Capital 193 (48.6) 
 
Non Capital 204 (51.4) 
Educational Degree Total 409 (100.0) 
 
Optometrist + Fellowship Strabismus 153 (37.4) 
 
Other fellow +General Ophthalmologist 256 (62.6) 
Practice status Total 363 (100.0) 
 
Faculty 70 (19.3) 
 
Non-Faculty 293 (80.7) 
Number of referral  Amblyopia (weekly) Total 419 (100.0) 
 
<=3 221 (52.7) 
 
>3 198 (47.3) 
Duration of Practice (years) Total 372 (100.0) 
 
<=10 178 (47.8) 




Figure 1. Mean Scores of Amblyopia Treatment Knowledge 
of Participants; D: Day, Ref: Refractive, Amb: Amblyopia, 
Yr: Year. 
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Table 1 shows the demographic characteristics, 
practice status, provinces, years of practice and the 
number of their referral amblyopic children per 
week. They were mostly male (64%) and aged 25-40 
year-old. Approximately half of the participants had 
a 10 year occupational record of working in Tehran 
and 20% had a practice status in a Medical 
university. Optometrists and pediatric fellows with 
an overall percentage of 37% were considered as the 
group 1 and others were regarded as the group 2. 
Table 2 and figure 1 imply the mean scores of 
participants’ information about the rate and types of 
patching method in various amblyopia, Atropine 
prescription, and efficiency of additive far or near 
daily working, first choice for treatment of bilateral 
refractive amblyopia, key points of treatment in older 
children (7-17 year-old), vision improvement rate by 
prescription of glasses only and amblyopia recurrence 
rate. As  seen in this table, the mean scores of group 1 
are more than the group 2, and except for the two 
groups of questions, one- additive far or near distance 
daily working (p value=0.202) and two-first choice for 
treatment of bilateral refractive amblyopia (p 
value=0.403), all had significant p values (all p  
value< 0.012). The worst and best scores referred to 
applying Atropine and prescription of glasses alone, 
respectively. The mean scores of other questions were 
about 50%. 
The information about mean scores of practitioners in 
accordance with their gender, province of practice, 
duration of practice and practice status are shown in 
table 3. In all parts, the female participants had better 





























<=10 >10 <=3 >3 
Patch 51 ± 15 44 ± 19 17 ± 46 19 ± 45 17 ± 48 18 ± 50 16 ± 45 19 ± 48 50 ± 16 45 ± 19 48 ± 18 47 ± 18 
Atropine 13.2 ± 19.4 11.2 ± 19.1 19.4 ± 10.6 18.8 ± 10.5 19.3 ± 13.2 19.5 ± 12 18.6 ± 13.2 19.9 ± 12.8 12 ± 18.6 13.2 ± 19.9 12.8 ± 19.9 12.3 ± 18.7 
Near or Far work 42.4 ± 20.3 46.8 ± 23 20.2 ± 43 23.1 ± 46.7 24.3 ± 44.1 20.9 ± 42.5 20 ± 48.3 22.5 ± 43.1 42.5 ± 20 48.3 ± 22.5 
43.1 ± 
20.83 
46.6 ± 23 
Ref Amb 72.5 ± 27 74.3 ± 27.3 25.6 ± 72.6 29.5 ± 73.6 27.9 ± 74.1 26.7 ± 75 25.6 ± 75.3 27.5 ± 72.6 75 ± 25.6 75.3 ± 27.5 72.6 ± 28.4 74.5 ± 27.5 
Treatment (7-17) 52.8 ± 20.4 49.5 ± 21.2 20.4 ± 47.6 21 ± 50 19.2 ± 51 21.4 ± 51.5 20.7 ± 51 21.2 ± 50.3 51.5 ± 20.7 51 ± 21.2 50.3 ± 20.1 50.4 ± 21.7 
Glass 97.3 ± 16.2 90.2 ± 29.9 21.1 ± 92.7 26.2 ± 94.3 23.4 ± 92.5 26.4 ± 94.4 23.1 ± 93.3 25.1 ± 94.1 94.4 ± 23.1 93.3 ± 25.1 94.1 ± 23.6 91.9 ± 27.3 
Recurrence 45.5 ± 49.9 38.7 ± 48.9 50.1 ± 35.8 48.1 ± 40 49. ± 42.7 49.5 ± 44.4 49.8 ± 42.3 49.5 ± 41.6 44.4 ± 49.8 42.3 ± 49.5 41.6 ± 49.4 42.9 ± 49.6 
Amb: Amblyopia, Yrs: Years, Ref: Refractive 
 
Table 2: Mean Scores of Participants in Relation to Different Amblyopia Treatments questions. 
  
Total   
Optometrist + Fellowship 
Strabismus 
Other fellow + General 
Ophthalmologist 
  p value* 
























Recurrence 42.3±49.46   50.98±50.15 37.11±48.4   0.006 
D: Day, Ref: Refractive, Amb: Amblyopia 
* All p values are by Mann-Whitney Test 
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mean scores than males except for refractive 
amblyopia treatment. Also, practitioners from Tehran 
revealed better knowledge about treatment in older 
children and amblyopia recurrence than others but 
there was no difference regarding having a practice 
status.   
Table 4 is based on Spearman correlation coefficient 
and p values of amblyopia treatment knowledge in 
relation to their epidemiologic characteristics. 
According to this table, younger practitioners have 
better answers to patching treatment and glasses 
prescription questions. Women had significantly 
higher scores about refractive amblyopia treatment, 
prescription of glasses and managing older children 
than their male colleagues. Practitioners from Tehran 
showed better scores in Atropine prescription, 
treatment of older children and recurrence rate with 
no relationship to their practice status or the number 
of referral amblyopia cases per week. Practitioners 
with less than 10 years of experience had better 
response to patching questions and those with more 
than 10 years of practice had better scores in 
questions related to additive far or near work daily. 
The average of Cronbach's α of this questionnaire 
was 0.57 for both groups. The reason for the small 
Cronbach's α in this questionnaire relates to the 
different answers of the two groups to specific 
questions. 
Discussion 
The purpose of this study was to recognize 
the amblyopia treatment knowledge of different 
groups of Iranian ophthalmologists and optometrists.  
The response rate of our study was 68.1%. Although it 
was not the optimal response rate, it was generally 
acceptable in comparison with other reports. In 
Khazaeni's study only 389 from 1200 mailed 




Seven scenarios according to recent publications of 
Pediatric Eye Disease Investigator Group trials were 
presented, each included patient with amblyopia and 
the practitioners were asked to choose from 6 
treatment options. They were asked to indicate their 
preferred initial treatment in 1998 and in 2004 to 
determine whether there has been a change in 
treatment practice patterns of amblyopia between these 
6 years or not. Results showed a change in practice 
patterns was observed for some of them
21
. 















Patch Correlation Coefficient --- -.191 --- --- --- -0.006 -.135 
 
p value .002 .000 .073 .125 .062 .898 .009 
Atropine Correlation Coefficient --- -0.064 --- --- --- -0.004 0.026 
 
p value .002 .228 .281 .030 .200 .937 .617 
Near or Far work Correlation Coefficient --- 0.096 --- --- --- 0.088 .136 
 
p value .202 .068 .502 .077 .420 .071 .009 
Ref Amb Correlation Coefficient --- 0.036 --- --- --- 0.031 0.015 
 
p value .575 .497 .024 .851 .952 .532 .772 
Treatment (7-17) Correlation Coefficient --- -0.096 --- --- --- -0.007 -0.013 
 
p value .000 .070 .002 .003 .665 .883 .806 
Glasses Correlation Coefficient --- -.149 --- --- --- -0.043 -0.022 
 
p value .012 .005 .044 .262 .602 .377 .666 
Recurrence Correlation Coefficient --- -0.068 --- --- --- 0.013 -0.021 
  p value .006 .198 .185 .007 .686 .789 .682 
Ref: Refractive, Amb: Amblyopia, p value: probability value 
* All p values are by Mann-Whitney Test 
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In Suttle et al. study, 400 questionnaires were sent to 
optometrists; only 179 were returned (44.75%), 
which is again less than ours. In their study rural or 
self- employed or full-time practice optometrists are 
less likely to refer the children elsewhere than those 
in cities
22
. The reason for their low response rates 
may be due to sending the questionnaires by mail, 
while in our study distribution and collection of 
questionnaires were done at approximately at the 
same time, which increased the response rate of the 
study.    
As shown in table 2 and figure 1, mean scores of the 
group 1 were significantly higher than the group 2 in 
all 7 categories of questions and in 5 of them the 
differences were statistically significant as expected 
from their special educational courses. 
The worst score was related to Atropine prescription 
and its replacement by patching in treatment of 
moderate amblyopia (12%) which can result in 
inappropriate or prescriptions being ignored. In 
ATS1, Repka et al. explained that patching and 
Atropine have the same effect on treatment of 
moderate amblyopia (V.A: 20/40 to 20/80)
9
; and in 
ATS4 it was implied that there was no difference 
between daily and weekend or twice a week 
prescriptions of Atropine
10
. Both methods improved 
vision about 2.3 lines after four months of therapy. 
Ignoring the fact that patching could be replaced by 
Atropine might have left poor cooperative or 
nystagmoid children untreated. 
The best score was related to the effect of prescribing 
glasses only on vision improvement. Paying attention 
to this subject would prevent unnecessary patching of 
amblyopic child simultaneously with glass 
prescription.  Scheiman et al. studied on 404 patients, 
7 to 12 year-old children, 25% who had two lines of 
VA improvement after 6 months by only wearing 
their prescription. Additional patching, Atropine and 
near work resulted in the same consequence in 53% 
of them as well
11
. 
The score of “first choice of treatment for refractive 
amblyopia" was also in an appropriate range (73%). 
It shows our practitioners had adequate knowledge 
about the prescription of glasses alone as a first 
choice and waiting for their vision to improve 
spontaneously.  In ATS7, Wallace et al. employed 
prescribing glasses alone for 113 bilateral refractive 
amblyopic 3-10 year-old children with a year of follow 




The mean scores of participants’ information for other 
questions were about 50%. Patching method is known 
as the first and most effective way to treat amblyopia. 
Unfortunately, the related scores were found to be 
average, which is a warning about the inadequate 
information for the correct application of this method.  
Spiritual problems of amblyopic children and their 
family and stopping follow up visits due to prolonged 
patching of the dominant eye would be expected. 
According to Repka and Holmes study in ATS2 , there 
is no difference between 12 hours and 6 hours of 
patching in deep amblyopia (VA<20/100), or 6 hours 
and 2 hours of patching in moderate amblyopia (VA 
20/40 to 20/80). So the practitioners are recommended 




The participants had the mean scores of 45% for the 
question of additional one hour daily far or near work, 
which is not an acceptable score. Inadequate 
information about the effect of daily work would 
increase the duration of amblyopia treatment. Wallace 
in ATS5 showed about 1.1 line vision improvement by 
adding one hour of near work in a five week follow-
up
15
. In ATS6, Holmes also explained that adding 
daily near work to the patching method can improve 
vision from 1.6 to 2.6 lines after one month follow up 
16
. 
The mean scores for treatment of older children were 
about 50%, which means that some of our 
practitioners do not believe in treating older children 
(7 to 17). By ignoring the treatment of older children, 
they would be deprived of trying to improve their 
vision. In ATS3 Scheiman studied on 404 patients 
between the ages of 7-12 and 103 patients between the 
ages 13-17 year-olds and employed a combination 
method of patching, Atropine, glasses and additional 
near work
11
. After six months of follow up, at least 
two lines of vision improvement was reported in 53% 
of children.  
The information about the prevalence of amblyopia 
recurrence rate was also inadequate (42%). Lack of 
participants awareness of amblyopia recurrence would 
lead to abruptly stopping the treatment after achieving 
20/20 visual acuity and not performing follow up on 
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the child occasionally, resulting in a high rate of 
recurrences. Holmes mentioned in ATS2c, 25% of 
their amblyopic children had recurrence in the one 
year follow-up after ceasing the treatment. He 
described how the sooner the treatment was stopped; 




Lack of attitude and practice evaluation, low 
response rate, closed answer questions were the 
limitations of our study. 
Conclusion 
Finally, considering the scores of participants 
suggests that Iranian practitioner knowledge about 
new methods of amblyopia treatment did not 
adequately correspond with all ATS’ results even in 
group 1 who were directly responsible for 
treating these children. We suggest paying more 
attention to new modified methods of amblyopia 
treatment and more discussion of them in our annual 
and CME meetings. 
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